700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Short Communication Open Access
Nanoparticles offer a distinct array of properties that may potentially improve cancer therapy. Nanoparticles possess an extraordinarily large surface-area-to-volume ratio for drug loading, increased blood circulation half-life, and inherent contrast enhancing properties for imaging purposes. Therefore, nanoparticle research has been exponentially accelerated for the past 15 years, and translational research greatly aided by the NCI Alliance for Nanotechnology in Cancer and Nanotechnology Characterization lab.
To read the full article Peer-reviewed Article PDF
Author(s): Forrest M. Kievit, Richard G. Ellenbogen and Miqin Zhang
Nanoparticles, polymeric targeted delivery, Genetic mutation, Pharmaceutics,Alternative Medicines,Biopharmaceutics